166 related articles for article (PubMed ID: 35207238)
1. Efficacy and Safety of the Hexanic Extract of
Alcaraz A; Gacci M; Ficarra V; Medina-Polo J; Salonia A; Fernández-Gómez JM; Ciudin A; Castro-Díaz D; Rodríguez-Antolín A; Carballido-Rodríguez J; Cózar-Olmo JM; Búcar-Terrades S; Pérez-León N; Brenes-Bermúdez FJ; Molero-García JM; Ledesma AF; Herdman M; Manasanch J; Angulo JC; Group OBOTQS
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207238
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of
Alcaraz A; Castro-Díaz D; Gacci M; Salonia A; Ficarra V; Carballido-Rodríguez J; Rodríguez-Antolín A; Medina-Polo J; Fernández-Gómez JM; Cózar-Olmo JM; Búcar-Terrades S; Pérez-León N; Brenes-Bermúdez FJ; Molero-García JM; Fernández-Pro-Ledesma A; Herdman M; Angulo JC; Manasanch J; On Behalf Of The Qualiprost Study Group
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806900
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients.
Alcaraz A; Rodríguez-Antolín A; Carballido-Rodríguez J; Castro-Díaz D; Medina-Polo J; Fernández-Gómez JM; Ficarra V; Palou J; Ponce de León Roca J; Angulo JC; Esteban-Fuertes M; Cózar-Olmo JM; Pérez-León N; Molero-García JM; Fernández-Pro Ledesma A; Brenes-Bermúdez FJ; Manasanch J
Sci Rep; 2021 Sep; 11(1):19401. PubMed ID: 34588509
[TBL] [Abstract][Full Text] [Related]
4. Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.
Alcaraz A; Rodríguez-Antolín A; Carballido-Rodríguez J; Castro-Díaz D; Esteban-Fuertes M; Cózar-Olmo JM; Ficarra V; Medina-López R; Fernández-Gómez JM; Angulo JC; Medina-Polo J; Brenes-Bermúdez FJ; Molero-García JM; Fernández-Pro-Ledesma A; Manasanch J; The Qualiprost Study Group OBO
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32917008
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Alcaraz A; Carballido-Rodríguez J; Unda-Urzaiz M; Medina-López R; Ruiz-Cerdá JL; Rodríguez-Rubio F; García-Rojo D; Brenes-Bermúdez FJ; Cózar-Olmo JM; Baena-González V; Manasanch J
Int Urol Nephrol; 2016 May; 48(5):645-56. PubMed ID: 26810324
[TBL] [Abstract][Full Text] [Related]
7. [Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study].
de la Taille A; Chalret du Rieu Q; Dialla O; Bardin L
Prog Urol; 2023 Feb; 33(2):66-72. PubMed ID: 36207246
[TBL] [Abstract][Full Text] [Related]
8. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
[TBL] [Abstract][Full Text] [Related]
9. The Role of Combination Therapy with α-Blockers and Hexanic Extract of
De Nunzio C; Salonia A; Gacci M; Ficarra V
J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498751
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
[TBL] [Abstract][Full Text] [Related]
11. Hexanic Extract of Serenoa repens (Permixon
Blair HA
Drugs Aging; 2022 Mar; 39(3):235-243. PubMed ID: 35237936
[TBL] [Abstract][Full Text] [Related]
12. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
13. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.
MacDonald R; Tacklind JW; Rutks I; Wilt TJ
BJU Int; 2012 Jun; 109(12):1756-61. PubMed ID: 22551330
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Impact of Hexanic Extract of
Samarinas M; Karatzas A; Tzortzis V; Gravas S
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235563
[TBL] [Abstract][Full Text] [Related]
15. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
De Nunzio C; Salonia A; Gacci M; Ficarra V
World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
[TBL] [Abstract][Full Text] [Related]
16. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
17. The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study.
Gravas S; Samarinas M; Zacharouli K; Karatzas A; Tzortzis V; Koukoulis G; Melekos M
World J Urol; 2019 Mar; 37(3):539-544. PubMed ID: 30027406
[TBL] [Abstract][Full Text] [Related]
18. [Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice].
Kuzmenko AV; Gyaurgiev TA; Kuzmenko GA
Urologiia; 2022 May; (2):84-89. PubMed ID: 35485819
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Ye Z; Huang J; Zhou L; Chen S; Wang Z; Ma L; Wang D; Wang G; Wang S; Liang C; Qiu S; Gu X; Liu J; Weng Z; Wu C; Wei Q; Xie L; Wu W; Cheng Y; Hu J; Wang Z; Zeng X
Urology; 2019 Jul; 129():172-179. PubMed ID: 30880074
[TBL] [Abstract][Full Text] [Related]
20. Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms.
Iacono F; Prezioso D; Illiano E; Ruffo A; Romeo G; Amato B
BMC Surg; 2012; 12 Suppl 1(Suppl 1):S22. PubMed ID: 23173650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]